Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Another Proof Shiseido will commercialize hair regeneration
View:
Post by MetzGER on Jun 11, 2024 6:37am

Another Proof Shiseido will commercialize hair regeneration

Article Date: 9th April 2024
https://prtimes.jp/story/detail/obenXOUaLgB

p> <a Inner Beauty Division Group Manager Keiichiro Kuno

 

Kosugi: I joined Shiseido about two years ago in 2022, and am currently in charge of research at the Mirai Development Research Institute that will expand fields for Shiseido, including food, hair regeneration medicine, and cosmetronics (beauty equipment, diagnostic equipment). doing.

Comment by Ingiboy on Jun 11, 2024 12:13pm
Metzger I think it is a leap of faith to think that this job search by Shiseido you have found proves that they are going to proceed to take Replicel's technology to market.  I think we would all love to see that because it would  give value to Replicel's rights to this hair procedure for all coiuntries outside of Asia. The key element for me is Andrew Schutte is investing even ...more  
Comment by bluemoons20 on Jun 11, 2024 12:34pm
All very  true,  but  the reality  is that  the proposition put forward  makes it a lot easier  for AS  to get  some or all of his money back that it does the other shareholders!! If  the  proposal  was  something  like a  50  - 50  split,  then I think  it would get some reasonable support  from  ...more  
Comment by Ingiboy on Jun 17, 2024 12:19pm
I think most of minority shareholders know this is a bad deal. Assuming the Directors who are also shareholders have examined this proposal what do they think of this lopsided deal ?  Are they getting some special status in the new AS company ?  if not I can't see how they would be voting in favour of this takeover.   There should be a SGM were all the Directors are present and ...more  
Comment by MetzGER on Jun 28, 2024 4:11pm
Whats Going on here?! it is obvious that Shiseido will commercialize hair regeneration. why Replicel isnt at the Stock Market anymore? we should now take Legal Action against Bord members. It is very strange what their Plans might be. The Court should decide if the Board members + CEO are a case of Insider deals. 
Comment by Ingiboy on Jun 28, 2024 8:31pm
Metzger I agree: what is going on here ?     If I had a sense of what the "plan" is I might be less impatient but this total blackout  has worn a little thin on us on the outside.  There is absolutely no reason we can't be told what the "plan" is.    The bigger question is why has the trading halt not been lifted ?  The 2023 Financials ...more